NEW YORK (GenomeWeb) – KeyGene today announced it has licensed its sequencing-based genotyping technology to the University of Edinburgh for research purposes.

The license includes access to and use of KeyGene's restricted-site associated DNA sequencing technology. The SBG technology enables the discovery and scoring of genetic variation for improving crops without prior knowledge of the genome sequence and provides researchers with a method to conduct genome-wide SNP discovery and genotyping in a single experiment, KeyGene said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.